WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles

New stock news | Zheneng Mai Ling submits forms to the Hong Kong Stock Exchange as a provider of green shipping equipment and systems.

New Stock News: Shenzhen Senior Technology Material (300568.SZ) has submitted a second application to the Hong Kong Stock Exchange as a manufacturer of lithium ion battery diaphragms.

New stock news | Taixi and Detection submit listing application to Hong Kong Stock Exchange, mainly engaged in testing, inspection, and certification solutions.
New stock news | Zheneng Mai Ling submits forms to the Hong Kong Stock Exchange as a provider of green shipping equipment and systems.

New Stock News: Shenzhen Senior Technology Material (300568.SZ) has submitted a second application to the Hong Kong Stock Exchange as a manufacturer of lithium ion battery diaphragms.

New stock news | Taixi and Detection submit listing application to Hong Kong Stock Exchange, mainly engaged in testing, inspection, and certification solutions.

RECOMMEND

Multiple A‑Share Companies Update Hong Kong IPO Progress Since Start Of Year
30/01/2026

Mainland Pharmaceutical Companies Rush To Hong Kong, Over 10 Firms Queue For IPO
30/01/2026

2026 Hong Kong Market Faces Unlocking Peak: HKD 1.6 Trillion In Restricted Shares To Be Released, How Will The Market Respond?
30/01/2026


